Desensitizing the cough reflex and new technologies based on artificial intelligence are some of the oral abstracts that Jacky Smith, MB, ChB, FRCP, PhD, professor of respiratory medicine at the University of Manchester and an honorary consultant at Manchester University NHS Foundation Trust, who chairs that session, is looking forward to at the American Cough Conference.
Transcript
As the chair of the oral abstracts, which ones are you particularly looking forward to being presented at the American Cough Conference?
I would say there's a couple of abstracts that I’m most looking forward to. There’s one about desensitizing the cough reflex in patients, which is something I'm quite interested in and curious about how they're going to achieve that, because that's an approach that you hear about in animal models of desensitizing the reflex, sometimes through stimulating it, but that we haven't seen much explored in humans.
And then the other one that is closest to my heart, well there are 2, really, that are close to my heart, [is] around cough monitoring. There's one about using artificial intelligence–based algorithms to try and detect cough automatically that I'm really interested to hear about. I helped develop the VitaloJAK cough monitor that's been commercialized by Vitalograph and is used in a lot of studies to test cough therapies at the moment. That's a semi-automated algorithm. And it would be great if we could push that forward to an algorithm that can fully automatically count cough, but in an accurate way. And that's super challenging to make that fully automatic, but still accurate. So I'm going to be really interested to see how that particular work pans out.
And then I guess I'll mention another abstract that's in there that does relate to the VitaloJAK that I know that Vitalograph have been working on, where they're looking at obfuscating speech and sound recordings from cough monitoring, because the way that we can monitor cough is by recording sounds that people make over a 24-hour period. And obviously, there are certain things you may pick up there when you're making those recordings that may be personal information or sensitive information. And in the interest of protecting people's data, it will be very useful to be able to obfuscate those sounds.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Prostate Cancer Studies Show Why Personalized Treatment, Trial Diversity Matter, Dorff Says
February 21st 2025Tanya B. Dorff, MD, medical oncologist and professor in City of Hope’s Department of Medical Oncology & Therapeutics Research, was a discussant for the TALAPRO-2 and STOPCAP trials at the opening session of ASCO GU.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More